{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:42:10Z","timestamp":1792896130612,"version":"4.5.0"},"reference-count":194,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Allogeneic hematopoietic cell transplantation (allo-HCT) is an essential therapeutic modality for patients with hematological malignancies and other blood disorders. Unfortunately, acute graft-versus-host disease (aGVHD) remains a major source of morbidity and mortality following allo-HCT, which limits its use in a broader spectrum of patients. Chronic graft-versus-host disease (cGVHD) also remains the most common long-term complication of allo-HCT, occurring in reportedly 30-70% of patients surviving more than 100 days. Chronic GVHD is also the leading cause of non-relapse mortality (NRM) occurring more than 2 years after HCT for malignant disease. Graft versus tumor (GVT) is a major component of the overall beneficial effects of allogeneic HCT in the treatment of hematological malignancies. Better understanding of GVHD pathogenesis is important to identify new therapeutic targets for GVHD prevention and therapy. Emerging data suggest opposing roles for different T cell subsets, e.g., IFN-\u03b3 producing CD4+ and CD8+ T cells (Th1 and Tc1), IL-4 producing T cells (Th2 and Tc2), IL-17 producing T cells (Th17 and Tc17), IL-9 producing T cells (Th9 and Tc9), IL-22 producing T cells (Th22), T follicular helper cells (Tfh), regulatory T-cells (Treg) and tissue resident memory T cells (Trm) in GVHD and GVT etiology. In this review, we first summarize the general description of the cytokine signals that promote the differentiation of T cell subsets and the roles of these T cell subsets in the pathogenesis of GVHD. Next, we extensively explore preclinical findings of T cell subsets in both GVHD\/GVT animal models and humans. Finally, we address recent findings about the roles of T-cell subsets in clinical GVHD and current strategies to modulate T-cell differentiation for treating and preventing GVHD in patients. Further exploring and outlining the immune biology of T-cell differentiation in GVHD that will provide more therapeutic options for maintaining success of allo-HCT.<\/jats:p>","DOI":"10.3389\/fimmu.2021.761448","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T18:59:49Z","timestamp":1633546789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":129,"title":["T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor"],"prefix":"10.3389","volume":"12","author":[{"given":"Hua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denggang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Bidgoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bjh.13959","article-title":"Advances in Understanding the Pathogenesis of Graft-Versus-Host Disease","volume":"173","author":"Magenau","year":"2016","journal-title":"Br J Haematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/bjh.14295","article-title":"Pathogenesis of Acute Graft-Versus-Host Disease: From Intestinal Microbiota Alterations to Donor T Cell Activation","volume":"175","author":"Zeiser","year":"2016","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2597","article-title":"Recipient Nonhematopoietic Antigen-Presenting Cells Are Sufficient to Induce Lethal Acute Graft-Versus-Host Disease","volume":"18","author":"Koyama","year":"2011","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nm1089","article-title":"Donor APCs Are Required for Maximal GVHD But Not for GVL","volume":"10","author":"Matte","year":"2004","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nm1309","article-title":"A Crucial Role for Antigen-Presenting Cells and Alloantigen Expression in Graft-Versus-Leukemia Responses","volume":"11","author":"Reddy","year":"2005","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384057","article-title":"Induction of Acute GVHD by Sex-Mismatched H-Y Antigens in the Absence of Functional Radiosensitive Host Hematopoietic-Derived Antigen-Presenting Cells","volume":"119","author":"Toubai","year":"2012","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2006-12-022038","article-title":"The Role of Antigen-Presenting Cells in Triggering Graft-Versus-Host Disease and Graft-Versus-Leukemia","volume":"110","author":"Chakraverty","year":"2007","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbmt.2005.11.519","article-title":"Graft-Versus-Leukemia and Graft-Versus-Host Reactions After Donor Lymphocyte Infusion Are Initiated by Host-Type Antigen-Presenting Cells and Regulated by Regulatory T Cells in Early and Long-Term Chimeras","volume":"12","author":"Xia","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri3212","article-title":"Advances in Graft-Versus-Host Disease Biology and Therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-Blood Stem Cells Versus Bone Marrow From Unrelated Donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic Graft-Versus-Host Disease: Biological Insights From Preclinical and Clinical Studies","volume":"129","author":"MacDonald","year":"2017","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-697250","article-title":"Alloantigen Presentation and Graft-Versus-Host Disease: Fuel for the Fire","volume":"127","author":"Koyama","year":"2016","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/2040620717741860","article-title":"New and Emerging Therapies for Acute and Chronic Graft Versus Host Disease","volume":"9","author":"Hill","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for Glucocorticoid-Refractory Acute Graft-Versus-Host Disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-Versus-Host Disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri3824","article-title":"The Development and In Vivo Function of T Helper 9 Cells","volume":"15","author":"Kaplan","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The Effects of IL-6 on CD4 T Cell Responses","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01212","article-title":"Effector T Helper Cell Subsets in Inflammatory Bowel Diseases","volume":"9","author":"Imam","year":"2018","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxw006","article-title":"CD4+ T-Cell Subsets in Inflammatory Diseases: Beyond the Th1\/Th2 Paradigm","volume":"28","author":"Hirahara","year":"2016","journal-title":"Int Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.smim.2016.02.001","article-title":"Role of Memory T Cell Subsets for Adoptive Immunotherapy","volume":"28","author":"Busch","year":"2016","journal-title":"Semin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00014","article-title":"Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation","volume":"6","author":"Ramadan","year":"2015","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170041","article-title":"Specifically Differentiated T Cell Subset Promotes Tumor Immunity Over Fatal Immunity","volume":"214","author":"Ramadan","year":"2017","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.22","article-title":"Ex Vivo T-Cell Depletion in Allogeneic Hematopoietic Stem Cell Transplant: Past, Present and Future","volume":"52","author":"Saad","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.pm11939605","article-title":"Poor Outcome in Steroid-Refractory Graft-Versus-Host Disease With Antithymocyte Globulin Treatment","volume":"8","author":"Arai","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738625","article-title":"A Phase 3 Randomized Trial Comparing Inolimomab vs Usual Care in Steroid-Resistant Acute GVHD","volume":"129","author":"Socie","year":"2017","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5441.958","article-title":"A Direct Estimate of the Human Alphabeta T Cell Receptor Diversity","volume":"286","author":"Arstila","year":"1999","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217604","article-title":"Comprehensive Assessment of T-Cell Receptor Beta-Chain Diversity in Alphabeta T Cells","volume":"114","author":"Robins","year":"2009","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T Cells do Not Induce Graft-Versus-Host Disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of Allogeneic CD62L- Memory T Cells Without Graft-Versus-Host Disease","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3135","article-title":"Dendritic Cell-Activated CD44hiCD8+ T Cells Are Defective in Mediating Acute Graft-Versus-Host Disease But Retain Graft-Versus-Leukemia Activity","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.10.6547","article-title":"Naive and Memory T Cells Induce Different Types of Graft-Versus-Host Disease","volume":"179","author":"Dutt","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-016410","article-title":"Inability of Memory T Cells to Induce Graft-Versus-Host Disease is a Result of an Abortive Alloresponse","volume":"109","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109678","article-title":"Effector Memory CD4+ T Cells Mediate Graft-Versus-Leukemia Without Inducing Graft-Versus-Host Disease","volume":"111","author":"Zheng","year":"2008","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802212","article-title":"Central Memory CD8+ T Cells Induce Graft-Versus-Host Disease and Mediate Graft-Versus-Leukemia","volume":"182","author":"Zheng","year":"2009","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-260539","article-title":"Leukemia-Associated Minor Histocompatibility Antigen Discovery Using T-Cell Clones Isolated by In Vitro Stimulation of Naive CD8+ T Cells","volume":"115","author":"Bleakley","year":"2010","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-367011","article-title":"Memory T Cells From Minor Histocompatibility Antigen-Vaccinated and Virus-Immune Donors Improve GVL and Immune Reconstitution","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81229","article-title":"Outcomes of Acute Leukemia Patients Transplanted With Naive T Cell-Depleted Stem Cell Grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current Concepts and Advances in Graft-Versus-Host Disease Immunology","volume":"39","author":"Hill","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 Responses and Enhanced Development of Th2 Cells in Stat4-Deficient Mice","volume":"382","author":"Kaplan","year":"1996","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1749-6632.1996.tb52655.x","article-title":"IL-12-Deficient Mice are Defective But Not Devoid of Type 1 Cytokine Responses","volume":"795","author":"Magram","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation Directs Memory Precursor and Short-Lived Effector CD8(+) T Cell Fates via the Graded Expression of T-Bet Transcription Factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","article-title":"Prolonged Interleukin-2Ralpha Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo","volume":"32","author":"Kalia","year":"2010","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","article-title":"Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs That Promote the Differentiation of Effector Cytolytic T Cells","volume":"32","author":"Pipkin","year":"2010","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two Types of Murine Helper T Cell Clone. I. Definition According to Profiles of Lymphokine Activities and Secreted Proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A Novel Transcription Factor, T-Bet, Directs Th1 Lineage Commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nri1490","article-title":"Recent Developments in the Transcriptional Regulation of Cytolytic Effector Cells","volume":"4","author":"Glimcher","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-063982","article-title":"IFNgamma Differentially Controls the Development of Idiopathic Pneumonia Syndrome and GVHD of the Gastrointestinal Tract","volume":"110","author":"Burman","year":"2007","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The Primacy of the Gastrointestinal Tract as a Target Organ of Acute Graft-Versus-Host Disease: Rationale for the Use of Cytokine Shields in Allogeneic Bone Marrow Transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-368076","article-title":"The Interferon-Dependent Orchestration of Innate and Adaptive Immunity After Transplantation","volume":"119","author":"Robb","year":"2012","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401618","article-title":"T-Bet is Critical for the Development of Acute Graft-Versus-Host Disease Through Controlling T Cell Differentiation and Function","volume":"194","author":"Fu","year":"2015","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-340315","article-title":"Prevention of GVHD While Sparing GVL Effect by Targeting Th1 and Th17 Transcription Factor T-Bet and RORgammat in Mice","volume":"118","author":"Yu","year":"2011","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF02918284","article-title":"Graft-Versus-Host Disease and the Th1\/Th2 Paradigm","volume":"15","author":"Krenger","year":"1996","journal-title":"Immunol Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06510.x","article-title":"Advances in the Understanding of Acute Graft-Versus-Host Disease","volume":"137","author":"Morris","year":"2007","journal-title":"Br J Haematol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.12.797","article-title":"The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia","volume":"24","author":"Schroeder","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01174-1","article-title":"Janus Kinase Inhibition for Graft-Versus-Host Disease: Current Status and Future Prospects","volume":"79","author":"Mannina","year":"2019","journal-title":"Drugs"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01360-9","article-title":"Baricitinib Prevents GvHD by Increasing Tregs via JAK3 and Treats Established GvHD by Promoting Intestinal Tissue Repair via EGFR","author":"Kim","year":"2021","journal-title":"Leukemia"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nature04754","article-title":"Transforming Growth Factor-Beta Induces Development of the T(H)17 Lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753","article-title":"Reciprocal Developmental Pathways for the Generation of Pathogenic Effector TH17 and Regulatory T Cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-Beta are Required for Differentiation of Human T(H)17 Cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939412","article-title":"A Th17-Like Developmental Process Leads to CD8(+) Tc17 Cells With Reduced Cytotoxic Activity","volume":"39","author":"Huber","year":"2009","journal-title":"Eur J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ni1261","article-title":"A Distinct Lineage of CD4 T Cells Regulates Tissue Inflammation by Producing Interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-Producing CD4+ Effector T Cells Develop via a Lineage Distinct From the T Helper Type 1 and 2 Lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The Orphan Nuclear Receptor RORgammat Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nri954","article-title":"The Lineage Decisions of Helper T Cells","volume":"2","author":"Murphy","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-256495","article-title":"Stem Cell Mobilization With G-CSF Induces Type 17 Differentiation and Promotes Scleroderma","volume":"116","author":"Hill","year":"2010","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.342","article-title":"Lack of IL-21 Signal Attenuates Graft-Versus-Leukemia Effect in the Absence of CD8 T-Cells","volume":"46","author":"Meguro","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.223","article-title":"IL-21 is Critical for GVHD in a Mouse Model","volume":"45","author":"Meguro","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 Blockade Reduces Graft-Versus-Host Disease Mortality by Supporting Inducible T Regulatory Cell Generation","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294785","article-title":"Abrogation of Donor T-Cell IL-21 Signaling Leads to Tissue-Specific Modulation of Immunity and Separation of GVHD From GVL","volume":"118","author":"Hanash","year":"2011","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200858","article-title":"Attenuation of Acute Graft-Versus-Host Disease in the Absence of the Transcription Factor RORgammat","volume":"189","author":"Fulton","year":"2012","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of Interleukin-6 Signaling Augments Regulatory T-Cell Reconstitution and Attenuates the Severity of Graft-Versus-Host Disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1078-0432.CCR-10-1198","article-title":"Interleukin-6 Modulates Graft-Versus-Host Responses After Experimental Allogeneic Bone Marrow Transplantation","volume":"17","author":"Tawara","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-175448","article-title":"Interleukin-23 Secretion by Donor Antigen-Presenting Cells is Critical for Organ-Specific Pathology in Graft-Versus-Host Disease","volume":"113","author":"Das","year":"2009","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.215","article-title":"Absence of IL-23p19 in Donor Allogeneic Cells Reduces Mortality From Acute GVHD","volume":"45","author":"Thompson","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-255422","article-title":"Blockade of Interleukin-23 Signaling Results in Targeted Protection of the Colon and Allows for Separation of Graft-Versus-Host and Graft-Versus-Leukemia Responses","volume":"115","author":"Das","year":"2010","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162420","article-title":"In Vitro-Differentiated TH17 Cells Mediate Lethal Acute Graft-Versus-Host Disease With Severe Cutaneous and Pulmonary Pathologic Manifestations","volume":"113","author":"Carlson","year":"2009","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.09.023","article-title":"T Helper17 Cells are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease","volume":"16","author":"Iclozan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181bc267e","article-title":"Interleukin-17-Producing T-Helper Cells as New Potential Player Mediating Graft-Versus-Host Disease in Patients Undergoing Allogeneic Stem-Cell Transplantation","volume":"88","author":"Dander","year":"2009","journal-title":"Transplantation"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-514372","article-title":"Diverse T-Cell Responses Characterize the Different Manifestations of Cutaneous Graft-Versus-Host Disease","volume":"123","author":"Bruggen","year":"2014","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3.3","article-title":"A Novel Th17-Prone CD146+CCR5+ T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease","volume":"124","author":"Li","year":"2014","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92111","article-title":"An Activated Th17-Prone T Cell Subset Involved in Chronic Graft-Versus-Host Disease Sensitive to Pharmacological Inhibition","volume":"2","author":"Forcade","year":"2017","journal-title":"JCI Insight"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-678706","article-title":"Targeted Rho-Associated Kinase 2 Inhibition Suppresses Murine and Human Chronic GVHD Through a Stat3-Dependent Mechanism","volume":"127","author":"Flynn","year":"2016","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02754","article-title":"ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study","author":"Cutler","year":"2021","journal-title":"Blood"},{"key":"B88","unstructured":"FDA Approves Belumosudil for Chronic Graft-Versus-Host DiseaseFood and Drug AdministrationFDA\/CEDR Resources Page"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40202","article-title":"Th22 Cells Represent a Distinct Human T Cell Subset Involved in Epidermal Immunity and Remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 Cells Form a Distinct Th Lineage From Th17 Cells In Vitro With Unique Transcriptional Properties and Tbet-Dependent Th1 Plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2013.05.005","article-title":"The Identification and Characteristics of IL-22-Producing T Cells in Acute Graft-Versus-Host Disease Following Allogeneic Bone Marrow Transplantation","volume":"218","author":"Zhao","year":"2013","journal-title":"Immunobiology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 Protects Intestinal Stem Cells From Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft Versus Host Disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/leu.2013.39","article-title":"IL-22 Deficiency in Donor T Cells Attenuates Murine Acute Graft-Versus-Host Disease Mortality While Sparing the Graft-Versus-Leukemia Effect","volume":"27","author":"Couturier","year":"2013","journal-title":"Leukemia"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2013.0099","article-title":"Interleukin-22 Aggravates Murine Acute Graft-Versus-Host Disease by Expanding Effector T Cell and Reducing Regulatory T Cell","volume":"34","author":"Zhao","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2021.03.008","article-title":"The Tissue Protective Functions of Interleukin-22 can be Decoupled From Pro-Inflammatory Actions Through Structure-Based Design","volume":"54","author":"Saxton","year":"2021","journal-title":"Immunity"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.12.124","article-title":"A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract","volume":"26","author":"Ponce","year":"2021","journal-title":"Biol Blood Marrow Transplant"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100853","article-title":"Cutting Edge: Dendritic Cell-Restricted Antigen Presentation Initiates the Follicular Helper T Cell Program But Cannot Complete Ultimate Effector Differentiation","volume":"187","author":"Goenka","year":"2011","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176676","article-title":"Bcl6 Mediates the Development of T Follicular Helper Cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.023","article-title":"ICOS Receptor Instructs T Follicular Helper Cell Versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6","volume":"34","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203032","article-title":"Cutting Edge: STAT1 is Required for IL-6-Mediated Bcl6 Induction for Early Follicular Helper Cell Differentiation","volume":"190","author":"Choi","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.009","article-title":"Opposing Signals From the Bcl6 Transcription Factor and the Interleukin-2 Receptor Generate T Helper 1 Central and Effector Memory Cells","volume":"35","author":"Pepper","year":"2011","journal-title":"Immunity"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180927","article-title":"Transient T-Bet Expression Functionally Specifies a Distinct T Follicular Helper Subset","volume":"215","author":"Fang","year":"2018","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111174","article-title":"STAT5 is a Potent Negative Regulator of TFH Cell Differentiation","volume":"209","author":"Johnston","year":"2012","journal-title":"J Exp Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200318","article-title":"IL-21 Promotes Lupus-Like Disease in Chronic Graft-Versus-Host Disease Through Both CD4 T Cell- and B Cell-Intrinsic Mechanisms","volume":"189","author":"Nguyen","year":"2012","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-688895","article-title":"Circulating T Follicular Helper Cells With Increased Function During Chronic Graft-Versus-Host Disease","volume":"127","author":"Forcade","year":"2016","journal-title":"Blood"},{"key":"B107","volume-title":"Blood","author":"Kamihara","year":"2017"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.078","article-title":"Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites","volume":"20","author":"Kumar","year":"2017","journal-title":"Cell Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129965","article-title":"Peripheral Host T Cells Survive Hematopoietic Stem Cell Transplantation and Promote Graft-Versus-Host Disease","volume":"130","author":"Divito","year":"2020","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb7028","article-title":"Long-Term Skin-Resident Memory T Cells Proliferate in Situ and are Involved in Human Graft-Versus-Host Disease","volume":"12","author":"Strobl","year":"2020","journal-title":"Sci Transl Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI135468","article-title":"Tissue-Resident PSGL1loCD4+ T Cells Promote B Cell Differentiation and Chronic Graft-Versus-Host Disease-Associated Autoimmunity","volume":"131","author":"Kong","year":"2021","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc0227","article-title":"Spatiotemporal Single-Cell Profiling Reveals That Invasive and Tissue-Resident Memory Donor CD8(+) T Cells Drive Gastrointestinal Acute Graft-Versus-Host Disease","volume":"13","author":"Tkachev","year":"2021","journal-title":"Sci Transl Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2010.24","article-title":"Understanding the Development and Function of T Follicular Helper Cells","volume":"7","author":"Nurieva","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The Transcription Factor GATA-3 is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.5.1715","article-title":"Generation of Polarized Antigen-Specific CD8 Effector Populations: Reciprocal Action of Interleukin (IL)-4 and IL-12 in Promoting Type 2 Versus Type 1 Cytokine Profiles","volume":"180","author":"Croft","year":"1994","journal-title":"J Exp Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00210-3","article-title":"CD8 T Cell-Specific Downregulation of Histone Hyperacetylation and Gene Activation of the IL-4 Gene Locus by ROG, Repressor of GATA","volume":"19","author":"Omori","year":"2003","journal-title":"Immunity"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3936","article-title":"CD3\/CD28-Costimulated T1 and T2 Subsets: Differential In Vivo Allosensitization Generates Distinct GVT and GVHD Effects","volume":"102","author":"Jung","year":"2003","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2008.02.010","article-title":"Combined Th2 Cytokine Deficiency in Donor T Cells Aggravates Experimental Acute Graft-vs-Host Disease","volume":"36","author":"Tawara","year":"2008","journal-title":"Exp Hematol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-219402","article-title":"Reciprocal Differentiation and Tissue-Specific Pathogenesis of Th1, Th2, and Th17 Cells in Graft-Versus-Host Disease","volume":"114","author":"Yi","year":"2009","journal-title":"Blood"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500117","article-title":"Cytokines in Graft-Versus-Host Disease","volume":"194","author":"Henden","year":"2015","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.05.014","article-title":"Ex Vivo Rapamycin Generates Th1\/Tc1 or Th2\/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-Transplant Rapamycin Therapy","volume":"12","author":"Jung","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-154278","article-title":"Graft Rejection as a Th1-Type Process Amenable to Regulation by Donor Th2-Type Cells Through an Interleukin-4\/STAT6 Pathway","volume":"112","author":"Mariotti","year":"2008","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-313684","article-title":"Rapamycin and IL-2 Reduce Lethal Acute Graft-Versus-Host Disease Associated With Increased Expansion of Donor Type CD4+CD25+Foxp3+ Regulatory T Cells","volume":"118","author":"Shin","year":"2011","journal-title":"Blood"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-446872","article-title":"Phase 2 Clinical Trial of Rapamycin-Resistant Donor CD4+ Th2\/Th1 (T-Rapa) Cells After Low-Intensity Allogeneic Hematopoietic Cell Transplantation","volume":"121","author":"Fowler","year":"2013","journal-title":"Blood"},{"key":"B125","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.immuni.2005.03.016","article-title":"PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells","volume":"22","author":"Chang","year":"2005","journal-title":"Immunity"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1659","article-title":"Transforming Growth Factor-Beta \u2019Reprograms\u2019 the Differentiation of T Helper 2 Cells and Promotes an Interleukin 9-Producing Subset","volume":"9","author":"Veldhoen","year":"2008","journal-title":"Nat Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1677","article-title":"IL-4 Inhibits TGF-Beta-Induced Foxp3+ T Cells and, Together With TGF-Beta, Generates IL-9+ IL-10+ Foxp3(-) Effector T Cells","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1867","article-title":"The Transcription Factor PU.1 Is Required for the Development of IL-9-Producing T Cells and Allergic Inflammation","volume":"11","author":"Chang","year":"2010","journal-title":"Nat Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242825","article-title":"Tc9 Cells, a New Subset of CD8(+) T Cells, Support Th2-Mediated Airway Inflammation","volume":"43","author":"Visekruna","year":"2013","journal-title":"Eur J Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e72305","DOI":"10.1371\/journal.pone.0072305","article-title":"Rapamycin Resistant Murine Th9 Cells Have a Stable In Vivo Phenotype and Inhibit Graft-Versus-Host Reactivity","volume":"8","author":"Mangus","year":"2013","journal-title":"PloS One"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65459","article-title":"Th9 Cells Promote Antitumor Immune Responses In Vivo","volume":"122","author":"Lu","year":"2012","journal-title":"J Clin Invest"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2856","article-title":"Robust Tumor Immunity to Melanoma Mediated by Interleukin-9-Producing T Cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 Axis in Immune Cells During Inflammatory Diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The Interleukin-1 Family: Back to the Future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a Marker for Risk of Therapy-Resistant Graft-Versus-Host Disease and Death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"308ra160","DOI":"10.1126\/scitranslmed.aab0166","article-title":"ST2 Blockade Reduces Sst2-Producing T Cells While Maintaining Protective Mst2-Expressing T Cells During Graft-Versus-Host Disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci Transl Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.12.6930","article-title":"T1\/ST2 is Preferentially Expressed on Murine Th2 Cells, Independent of Interleukin 4, Interleukin 5, and Interleukin 10, and Important for Th2 Effector Function","volume":"95","author":"Lohning","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.5.787","article-title":"Selective Expression of a Stable Cell Surface Molecule on Type 2 But Not Type 1 Helper T Cells","volume":"187","author":"Xu","year":"1998","journal-title":"J Exp Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e21695","DOI":"10.1371\/journal.pone.0021695","article-title":"IL-33 Induces IL-9 Production in Human CD4+ T Cells and Basophils","volume":"6","author":"Blom","year":"2011","journal-title":"PloS One"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171576","article-title":"Cholesterol Negatively Regulates IL-9-Producing CD8(+) T Cell Differentiation and Antitumor Activity","volume":"215","author":"Ma","year":"2018","journal-title":"J Exp Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9615","article-title":"Biomarker Panel for Chronic Graft-Versus-Host Disease","volume":"34","author":"Yu","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1126\/science.1133715","article-title":"Amphiregulin, a TH2 Cytokine Enhancing Resistance to Nematodes","volume":"314","author":"Zaiss","year":"2006","journal-title":"Science"},{"key":"B143","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.immuni.2018.04.023","article-title":"Amphiregulin-Producing Pathogenic Memory T Helper 2 Cells Instruct Eosinophils to Secrete Osteopontin and Facilitate Airway Fibrosis","volume":"49","author":"Morimoto","year":"2018","journal-title":"Immunity"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A Distinct Function of Regulatory T Cells in Tissue Protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122014","article-title":"Rorc Restrains the Potency of ST2+ Regulatory T Cells in Ameliorating Intestinal Graft-Versus-Host Disease","volume":"4","author":"Yang","year":"2019","journal-title":"JCI Insight"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.1.280","article-title":"IL-2 Receptor Beta-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells","volume":"178","author":"Burchill","year":"2007","journal-title":"J Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/ni1263","article-title":"A Function for Interleukin 2 in Foxp3-Expressing Regulatory T Cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402144","article-title":"Differential Requirement for IL-2 and IL-15 During Bifurcated Development of Thymic Regulatory T Cells","volume":"193","author":"Marshall","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1607","article-title":"A Critical Function for TGF-Beta Signaling in the Development of Natural CD4+CD25+Foxp3+ Regulatory T Cells","volume":"9","author":"Liu","year":"2008","journal-title":"Nat Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1609337","article-title":"Acute Graft-Versus-Host Disease - Biologic Process, Prevention, and Therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-091074","article-title":"Absence of Regulatory T-Cell Control of TH1 and TH17 Cells Is Responsible for the Autoimmune-Mediated Pathology in Chronic Graft-Versus-Host Disease","volume":"110","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.44","article-title":"Type 1 Regulatory T Cells: A New Mechanism of Peripheral Immune Tolerance","volume":"12","author":"Zeng","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah7152","article-title":"Eomesodermin Promotes the Development of Type 1 Regulatory T (TR1) Cells","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ Regulatory T Cells Preserve Graft-Versus-Tumor Activity While Inhibiting Graft-Versus-Host Disease After Bone Marrow Transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17702","article-title":"Recipient-Type Specific CD4+CD25+ Regulatory T Cells Favor Immune Reconstitution and Control Graft-Versus-Host Disease While Maintaining Graft-Versus-Leukemia","volume":"112","author":"Trenado","year":"2003","journal-title":"J Clin Invest"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151563","article-title":"Exogenous TNFR2 Activation Protects From Acute GvHD via Host T Reg Cell Expansion","volume":"213","author":"Chopra","year":"2016","journal-title":"J Exp Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-Specific Regulatory T Cells Generated With a Chimeric Antigen Receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high Regulatory Cells in Human Peripheral Blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"83ra41","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive Ex Vivo Expansion of Human Natural Regulatory T Cells (T(regs)) With Minimal Loss of In Vivo Functional Activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.smim.2006.01.006","article-title":"Clinical Application of Expanded CD4+25+ Cells","volume":"18","author":"June","year":"2006","journal-title":"Semin Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0151","article-title":"In Vitro-Expanded Human CD4(+)CD25(+) T-Regulatory Cells can Markedly Inhibit Allogeneic Dendritic Cell-Stimulated MLR Cultures","volume":"104","author":"Godfrey","year":"2004","journal-title":"Blood"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of Ex Vivo Expanded T Regulatory Cells in Adults Transplanted With Umbilical Cord Blood: Safety Profile and Detection Kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical Cord Blood-Derived T Regulatory Cells to Prevent GVHD: Kinetics, Toxicity Profile, and Clinical Effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs Prevent GVHD and Promote Immune Reconstitution in HLA-Haploidentical Transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2073","article-title":"Chronic Graft-Versus-Host Disease is Associated With Increased Numbers of Peripheral Blood CD4+CD25high Regulatory T Cells","volume":"103","author":"Clark","year":"2004","journal-title":"Blood"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00016","article-title":"Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated With IL-10-Anergized Donor T Cells","volume":"5","author":"Bacchetta","year":"2014","journal-title":"Front Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71017-4","article-title":"Addition of Interleukin-6 Inhibition With Tocilizumab to Standard Graft-Versus-Host Disease Prophylaxis After Allogeneic Stem-Cell Transplantation: A Phase 1\/2 Trial","volume":"15","author":"Kennedy","year":"2014","journal-title":"Lancet Oncol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009050","article-title":"A Phase 3 Double-Blind Study of the Addition of Tocilizumab vs Placebo to Cyclosporin\/Methotrexate GVHD Prophylaxis","volume":"137","author":"Kennedy","year":"2021","journal-title":"Blood"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/nri775","article-title":"Cytolytic Pathways in Haematopoietic Stem-Cell Transplantation","volume":"2","author":"van den Brink","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1317431111","article-title":"Tumor-Specific IL-9-Producing CD8+ Tc9 Cells are Superior Effector Than Type-I Cytotoxic Tc1 Cells for Adoptive Immunotherapy of Cancers","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B171","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1038\/s41467-020-19672-2","article-title":"Enhanced CAR-T Activity Against Established Tumors by Polarizing Human T Cells to Secrete Interleukin-9","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000951","article-title":"Cellular Therapies for Graft-Versus-Host Disease: A Tale of Tissue Repair and Tolerance","volume":"136","author":"Voermans","year":"2020","journal-title":"Blood"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-785865","article-title":"Immune Regulatory Cell Infusion for Graft-Versus-Host Disease Prevention and Therapy","volume":"131","author":"Blazar","year":"2018","journal-title":"Blood"},{"key":"B174","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","article-title":"The Emerging Landscape of Immune Cell Therapies","volume":"181","author":"Weber","year":"2020","journal-title":"Cell"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-019-0074-7","article-title":"Delivering Cellular and Gene Therapies to Patients: Solutions for Realizing the Potential of the Next Generation of Medicine","volume":"27","author":"Elverum","year":"2020","journal-title":"Gene Ther"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.6.3872","article-title":"Bruton\u2019s Tyrosine Kinase Mediates NF-Kappa B Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family","volume":"179","author":"Shinners","year":"2007","journal-title":"J Immunol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an Irreversible Molecular Inhibitor of ITK Driving a Th1-Selective Pressure in T Lymphocytes","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75328","article-title":"Ibrutinib Treatment Ameliorates Murine Chronic Graft-Versus-Host Disease","volume":"124","author":"Dubovsky","year":"2014","journal-title":"J Clin Invest"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"key":"B180","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","article-title":"The Janus Kinases (Jaks)","volume":"5","author":"Yamaoka","year":"2004","journal-title":"Genome Biol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-543736","article-title":"Activity of Therapeutic JAK 1\/2 Blockade in Graft-Versus-Host Disease","volume":"123","author":"Spoerl","year":"2014","journal-title":"Blood"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-484642","article-title":"The JAK-Inhibitor Ruxolitinib Impairs Dendritic Cell Function In Vitro and In Vivo","volume":"122","author":"Heine","year":"2013","journal-title":"Blood"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-363408","article-title":"Janus Kinase-2 Inhibition Induces Durable Tolerance to Alloantigen by Human Dendritic Cell-Stimulated T Cells Yet Preserves Immunity to Recall Antigen","volume":"118","author":"Betts","year":"2011","journal-title":"Blood"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-403196","article-title":"IFNgammaR Signaling Mediates Alloreactive T-Cell Trafficking and GVHD","volume":"120","author":"Choi","year":"2012","journal-title":"Blood"},{"key":"B185","doi-asserted-by":"publisher","first-page":"e109799","DOI":"10.1371\/journal.pone.0109799","article-title":"Pharmacologic Blockade of JAK1\/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect","volume":"9","author":"Choi","year":"2014","journal-title":"PloS One"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in Corticosteroid-Refractory Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation: A Multicenter Survey","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001043","article-title":"A Phase 1 Trial of Itacitinib, a Selective JAK1 Inhibitor, in Patients With Acute Graft-Versus-Host Disease","volume":"4","author":"Schroeder","year":"2020","journal-title":"Blood Adv"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-415422","article-title":"Expression of CD30 in Patients With Acute Graft-Versus-Host Disease","volume":"120","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-772210","article-title":"Phase 1 Multicenter Trial of Brentuximab Vedotin for Steroid-Refractory Acute Graft-Versus-Host Disease","volume":"129","author":"Chen","year":"2017","journal-title":"Blood"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003739","article-title":"Natalizumab-Associated PML: Challenges With Incidence, Resulting Risk, and Risk Stratification","volume":"88","author":"Schwab","year":"2017","journal-title":"Neurology"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.2217\/imt.14.66","article-title":"Vedolizumab for Ulcerative Colitis and Crohn\u2019s Disease: Results and Implications of GEMINI Studies","volume":"6","author":"Lam","year":"2014","journal-title":"Immunotherapy"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.08.011","article-title":"Vedolizumab, a Monoclonal Antibody to the Gut Homing Alpha4beta7 Integrin, Does Not Affect Cerebrospinal Fluid T-Lymphocyte Immunophenotype","volume":"264","author":"Milch","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.153973","article-title":"The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-Alpha4beta7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases","volume":"330","author":"Soler","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.10.009","article-title":"Targeting Integrin Alpha4beta7 in Steroid-Refractory Intestinal Graft-Versus-Host Disease","volume":"23","author":"Floisand","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.761448\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T05:59:19Z","timestamp":1673416759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.761448\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":194,"alternative-id":["10.3389\/fimmu.2021.761448"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.761448","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"article-number":"761448"}}